Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer
Jinpeng Shi,Jiayu Li,Haowei Wang,Xuefei Li,Qi Wang,Chao Zhao,Lei Cheng,Ruoshuang Han,Peixin Chen,Haoyue Guo,Zhuoran Tang,Caicun Zhou,Zhemin Zhang,Fengying Wu
DOI: https://doi.org/10.2147/lctt.s430967
2023-11-22
Lung Cancer Targets and Therapy
Abstract:Jinpeng Shi, 1, &ast Jiayu Li, 1, &ast Haowei Wang, 1, &ast Xuefei Li, 2 Qi Wang, 1 Chao Zhao, 2 Lei Cheng, 2 Ruoshuang Han, 1 Peixin Chen, 1 Haoyue Guo, 1 Zhuoran Tang, 1 Caicun Zhou, 1 Zhemin Zhang, 1 Fengying Wu 1 1 Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, School of Medicine, Tongji University, Shanghai, People's Republic of China; 2 Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fengying Wu; Zhemin Zhang, Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, School of Medicine, Tongji University, No. 507, Zheng Min Road, Shanghai, 200433, People's Republic of China, Tel +86 21 6511 5006, Email ; Purpose: Neutrophils act as a non-negligible regulator in the initiation and progression of malignancies, playing bifacial roles in the process. Thus, to understand the heterogeneity of tumor-associated neutrophils (TANs) comprehensively in advanced non-small cell lung cancer (NSCLC) at single-cell resolution is necessary and urgent. Materials and Methods: We applied single-cell RNA-sequencing (scRNA-seq) to portray the subtype-specific transcriptome landscape of TANs in advanced NSCLC using nine freshly obtained specimens. The scRNA-seq data were further processed for pseudo-time analysis to depict the developmental trajectory of TANs. Meanwhile, the interplay between TANs and other cell types within tumor microenvironment (TME) was revealed by intercellular interaction analysis. Results: Seven distinct TAN subtypes were defined, of which, the N 3 cluster was considered inflammatory phenotype expressing genes encoding multiple chemotactic cytokines, and correlated with inferior overall survival, indicating that N 3 might be a pro-tumorigenic TAN subtype. N 1 and N 5 clusters were considered to be well differentiated and mature neutrophils based on CXCR2 expression and pseudo-time patterns, and both accounted for relatively high proportions in lung adenocarcinoma. In addition, genes related to neutrophil differentiation were discovered. We also found that TAN subtypes interacted most closely with macrophages through chemokine signaling pathways within TME. Conclusion: Our study refined TAN subtypes and mapped the transcriptome landscape of TANs at single-cell resolution in advanced NSCLC, collectively indicating the heterogeneity of TANs in NSCLC. Neutrophil differentiation- and maturation-related genes were also discovered, which shed light on different functions of TAN subclones in tumor immune escape, and may further provide novel targets for immunotherapy. Keywords: tumor-associated neutrophil, single-cell RNA-sequencing, non-small cell lung cancer, tumor microenvironment, heterogeneity Graphical Neutrophils are the most abundant population of immune cells in human peripheral circulation, and the defense of the innate immune system at the frontline against invading pathogens. 1–4 Notwithstanding, the roles played by neutrophils in regulating tumor immunity by interacting with other immune cells in the tumor microenvironment (TME) had been ignored for a long time. Recently, neutrophil-based indexes [eg, neutrophil-to-lymphocyte ratio (NLR) and derived NLR (dNLR)] are receiving increasing attention for their potential predictive and prognostic value in anti-cancer treatment. For example, a retrospective cohort study performed by Valero et al 5 illustrated that an elevated pretreatment blood NLR was associated with inferior progression-free survival, overall survival (OS), response rate, and clinical benefit across multiple cancer types administered with immune checkpoint inhibitors including non-small cell lung cancer (NSCLC), implying its potential predictive and prognostic value in this scenario. In addition, the function of neutrophils in tumor immunity is gradually being disclosed, albeit to some extent contradictory. A number of studies have demonstrated that tumor-associated neutrophils (TANs) perform a completely different role in different periods of tumorigenesis and development. TANs are anti-tumorigenic in the early stages of malignant tumors, but pro-tumorigenic in the late stages. Eruslanov et al 6 found that TANs exhibited CD62L lo CD54 hi activated phenotype at early stages of lung cancer with a broad variety of chemokine receptor -Abstract Truncated-
English Else